Movano Inc. (NASDAQ:MOVE – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $10.06 and traded as high as $12.69. Movano shares last traded at $11.05, with a volume of 138,127 shares traded.
Key Movano News
Here are the key news stories impacting Movano this week:
- Positive Sentiment: Broader market tailwind from easing geopolitical risk could support a rebound in small-cap and tech names if risk appetite persists. U.S. Stocks Move Sharply Higher On News Of U.S.-Iran Ceasefire
- Neutral Sentiment: Technical context is mixed: the 200-day moving average (~$10.05) provides a potential longer-term floor, while the 50-day (~$13.42) sits above the current price, signalling near-term weakness. Investors should watch volume to confirm any reversal. More stock data (volume, SMAs, 52-week range) is here. Movano stock
- Negative Sentiment: Recent earnings and fundamentals remain the main headwind: Movano reported a March-quarter EPS of ($5.88) vs. consensus (~($3.60)) and revenue of $0.04M vs. ~$7.6M expected — an outsized miss that highlights extremely negative margins and raises dilution / financing concerns for a company with a market cap in the low tens of millions. That miss is the likeliest proximate cause of today’s selloff. See company metrics and recent results. Movano stock
Wall Street Analysts Forecast Growth
Several research analysts have commented on MOVE shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Movano has an average rating of “Sell”.
Movano Stock Performance
The business has a 50 day moving average of $13.28 and a two-hundred day moving average of $10.06. The firm has a market capitalization of $13.37 million, a price-to-earnings ratio of -1.04 and a beta of 0.71.
Movano (NASDAQ:MOVE – Get Free Report) last issued its quarterly earnings data on Monday, March 30th. The technology company reported ($5.88) EPS for the quarter, missing analysts’ consensus estimates of ($3.60) by ($2.28). The company had revenue of $0.04 million for the quarter, compared to the consensus estimate of $7.63 million. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.
Insider Activity
In other news, CTO Michael Aaron Leabman sold 6,845 shares of the company’s stock in a transaction that occurred on Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the transaction, the chief technology officer directly owned 22,639 shares of the company’s stock, valued at $150,775.74. This represents a 23.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jeremy Cogan sold 28,736 shares of the company’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $20.78, for a total value of $597,134.08. Following the completion of the transaction, the chief financial officer directly owned 60,504 shares of the company’s stock, valued at approximately $1,257,273.12. This represents a 32.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 74,886 shares of company stock valued at $1,374,330 over the last three months. Corporate insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Movano
An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC acquired a new stake in shares of Movano Inc. (NASDAQ:MOVE – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent quarter. Institutional investors and hedge funds own 16.64% of the company’s stock.
Movano Company Profile
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
See Also
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
